Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Rangering i aksjer #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$1.17K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel PhaseRx, Inc. (PZRXQ)

Kategori

Utbytteavkastning for PhaseRx, Inc. (PZRXQ)
PhaseRx, Inc. (aksjesymbol: PZRXQ) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for PhaseRx, Inc. (PZRXQ) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter